Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday&#3

Dow gains over 150 points, NASDAQ and S&P 500 also up. Consumer discretionary shares jump 1.2%,

US stocks traded higher with Dow up 150 points. Consumer discretionary shares surged 1.3% while heal

Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's

SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF) (the “Company”),

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line

-​ The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + s

SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage

Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Resident

Updated Phase 2 CRDF-004 data to be presented during ASCO 2026 rapid oral session on June 2, 2026; i

Cardiff Oncology Inc. (NASDAQ:CRDF) on Tuesday said that it filed a lawsuit against Nerviano Medical

Completed successful End-of-Phase 2 meeting with the FDA and selected onvansertib dose and chemother

SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clini

SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stag

SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stag

Onvansertib in combination with trastuzumab deruxtecan demonstrated enhanced antitumor activity, inc

Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive Officer Appoint

Cardiff Oncology posted Phase II data for onvansertib in RAS-mutated mCRC, showing a 72% ORR versus

Cardiff Oncology, Inc. (CRDF) Discusses Advances in First-Line Treatment for RAS-Mutated Metastatic

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stag

Preclinical results in therapy-resistant HER2-low breast cancer models demonstrate enhanced antitumo

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) and Cardiff Oncology (NASDAQ: CRDF - Get Free

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-q

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 2

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12

  On Wednesday, 807 companies reached new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

  On Friday, 431 companies hit new 52-week lows.

  On Tuesday, 242 companies hit new 52-week lows.

    Tuesday's session saw 729 companies set new 52-week lows.

    On Monday, 524 stocks hit new 52-week lows.

    On Wednesday, 348 companies hit new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

    On Friday, 209 companies set new 52-week lows.

    During Wednesday's morning trading, 400 companies set new 52-week lows.

  Tuesday's morning session saw 195 companies set new 52-week highs.

  On Monday morning, 204 companies hit new 52-week highs.

Gainers

Gainers Marathon Patent Group, Inc. (NASDAQ: MARA) shares surged 88.7% to close at $3.83 on Mond